首页> 外文期刊>Stem cells international >Stem Cells for Cardiac Repair: Status, Mechanisms, and New Strategies
【24h】

Stem Cells for Cardiac Repair: Status, Mechanisms, and New Strategies

机译:用于心脏修复的干细胞:状态,机制和新策略

获取原文
           

摘要

Faced with the end stage of heart disease, the current treatments only slow worsening of heart failure. Stem cells have the potential of self-renewal and differentiation. It is expected to replace and repair damaged myocardium. But many clinical trials have shown that the stem cell therapy of heart failure is modest or not effective. The possible causes for the limited effects of stem cell in curing heart failure are the stem cells which have been transplanted into the ischemic heart muscle may suffer low survival rate, affected by inflammatory molecules, proapoptotic factor, and lack of nutrients and oxygen, and then the stem cells which home and have been completely transplanted to the site of myocardial infarction become very small. Therefore, through preconditioning of stem cells and appropriate choice of genes for mesenchymal stem cell modification to improve the survival rate of stem cells, ability in homing and promoting angiogenesis may become the newly effective strategies for the application of stem cells therapy in heart failure.
机译:面对心脏病的终末期,当前的治疗只能减缓心力衰竭的恶化。干细胞具有自我更新和分化的潜力。有望更换和修复受损的心肌。但是许多临床试验表明,干细胞治疗心力衰竭是适度的或无效的。干细胞在治疗心力衰竭中作用有限的可能原因是,已移植到缺血性心肌中的干细胞存活率低,受到炎症分子,促凋亡因子以及缺乏营养和氧气的影响,然后完全移植到心肌梗塞部位的干细胞非常小。因此,通过干细胞和基因间充质干细胞改性,提高干细胞能力的归巢存活率的适当选择的预处理,促进血管新生可能成为干细胞治疗心脏衰竭的应用,新的有效策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号